Exercise Beat TRT in Middle-Aged Men
Why It Matters
The study shows exercise outperforms testosterone therapy in enhancing fitness and strength for middle‑aged men with low‑normal testosterone, guiding providers toward non‑pharmacologic anti‑aging strategies.
Key Takeaways
- •Exercise improved aerobic capacity 10‑13% in 12 weeks
- •Testosterone alone did not enhance aerobic fitness or strength
- •Both exercise and testosterone increased muscle mass independently
- •Combining testosterone with exercise offered no extra strength gains
- •Authors recommend exercise over testosterone for anti‑aging intervention
Summary
A 12‑week Australian trial enrolled 80 men in their 50s and 60s with average testosterone of 320 ng/dL and visceral obesity (waist ≥37 in). Participants were randomized to four arms: prescription testosterone alone, supervised exercise alone, both interventions, or neither.
After 12 weeks, the exercise groups boosted aerobic capacity by 10‑13%, while the testosterone‑only group showed no change. Both testosterone and exercise independently increased lean muscle mass, but only exercise drove measurable strength gains across all tests.
The combination of testosterone and exercise did not produce statistically significant additional benefits over exercise alone, and the authors concluded that exercise should be evaluated as the preferred anti‑aging intervention for this demographic.
For clinicians and wellness clinics targeting middle‑aged men with low‑normal testosterone, the findings suggest prioritizing structured exercise programs over testosterone replacement, potentially reducing drug exposure and associated costs while delivering superior functional outcomes.
Comments
Want to join the conversation?
Loading comments...